Cargando…
A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches
This paper addresses the dynamics of lung cancer by employing a fractional-order mathematical model that investigates the combined therapy of surgery and immunotherapy. The significance of this study lies in its exploration of the effects of surgery and immunotherapy on tumor growth rate and the imm...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394091/ https://www.ncbi.nlm.nih.gov/pubmed/37528101 http://dx.doi.org/10.1038/s41598-023-38814-2 |
_version_ | 1785083292154855424 |
---|---|
author | Amilo, David Kaymakamzade, Bilgen Hincal, Evren |
author_facet | Amilo, David Kaymakamzade, Bilgen Hincal, Evren |
author_sort | Amilo, David |
collection | PubMed |
description | This paper addresses the dynamics of lung cancer by employing a fractional-order mathematical model that investigates the combined therapy of surgery and immunotherapy. The significance of this study lies in its exploration of the effects of surgery and immunotherapy on tumor growth rate and the immune response to cancer cells. To optimize the treatment dosage based on tumor response, a feedback control system is designed using control theory, and Pontryagin’s Maximum Principle is utilized to derive the necessary conditions for optimality. The results reveal that the reproduction number [Formula: see text] is 2.6, indicating that a lung cancer cell would generate 2.6 new cancer cells during its lifetime. The reproduction coefficient [Formula: see text] is 0.22, signifying that cancer cells divide at a rate that is 0.22 times that of normal cells. The simulations demonstrate that the combined therapy approach yields significantly improved patient outcomes compared to either treatment alone. Furthermore, the analysis highlights the sensitivity of the steady-state solution to variations in [Formula: see text] (the rate of division of cancer stem cells) and [Formula: see text] (the rate of differentiation of cancer stem cells into progenitor cells). This research offers clinicians a valuable tool for developing personalized treatment plans for lung cancer patients, incorporating individual patient factors and tumor characteristics. The novelty of this work lies in its integration of surgery, immunotherapy, and control theory, extending beyond previous efforts in the literature. |
format | Online Article Text |
id | pubmed-10394091 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-103940912023-08-03 A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches Amilo, David Kaymakamzade, Bilgen Hincal, Evren Sci Rep Article This paper addresses the dynamics of lung cancer by employing a fractional-order mathematical model that investigates the combined therapy of surgery and immunotherapy. The significance of this study lies in its exploration of the effects of surgery and immunotherapy on tumor growth rate and the immune response to cancer cells. To optimize the treatment dosage based on tumor response, a feedback control system is designed using control theory, and Pontryagin’s Maximum Principle is utilized to derive the necessary conditions for optimality. The results reveal that the reproduction number [Formula: see text] is 2.6, indicating that a lung cancer cell would generate 2.6 new cancer cells during its lifetime. The reproduction coefficient [Formula: see text] is 0.22, signifying that cancer cells divide at a rate that is 0.22 times that of normal cells. The simulations demonstrate that the combined therapy approach yields significantly improved patient outcomes compared to either treatment alone. Furthermore, the analysis highlights the sensitivity of the steady-state solution to variations in [Formula: see text] (the rate of division of cancer stem cells) and [Formula: see text] (the rate of differentiation of cancer stem cells into progenitor cells). This research offers clinicians a valuable tool for developing personalized treatment plans for lung cancer patients, incorporating individual patient factors and tumor characteristics. The novelty of this work lies in its integration of surgery, immunotherapy, and control theory, extending beyond previous efforts in the literature. Nature Publishing Group UK 2023-08-01 /pmc/articles/PMC10394091/ /pubmed/37528101 http://dx.doi.org/10.1038/s41598-023-38814-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Amilo, David Kaymakamzade, Bilgen Hincal, Evren A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title | A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title_full | A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title_fullStr | A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title_full_unstemmed | A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title_short | A fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
title_sort | fractional-order mathematical model for lung cancer incorporating integrated therapeutic approaches |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394091/ https://www.ncbi.nlm.nih.gov/pubmed/37528101 http://dx.doi.org/10.1038/s41598-023-38814-2 |
work_keys_str_mv | AT amilodavid afractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches AT kaymakamzadebilgen afractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches AT hincalevren afractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches AT amilodavid fractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches AT kaymakamzadebilgen fractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches AT hincalevren fractionalordermathematicalmodelforlungcancerincorporatingintegratedtherapeuticapproaches |